The amino acid residues at 102 and 104 in GP5 of porcine reproductive and respiratory syndrome virus regulate viral neutralization susceptibility to the porcine serum neutralizing antibody

Virus Research

Volumn 204, Issue , 2015, Pages 21-30

  Fan, Baochao ^a   Liu, Xing ^a   Bai, Juan ^a   Zhang, Tingjie ^a   Zhang, Qiaoya ^a   Jiang, Ping ^a,b  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

102 and 104; Neutralizing antibody; PRRSV

Indexed keywords

AMINO ACID; EPITOPE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN GP5; GLYCOPROTEIN 5, PRRSV; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; REVERSE GENETICS; REVERTANT; SERUM; VIRAL PLAQUE ASSAY; VIRUS NEUTRALIZATION; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; DNA SEQUENCE; GENETICS; HAPLORHINI; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; SEQUENCE ALIGNMENT; SERODIAGNOSIS;

PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; EPITOPES; HAPLORHINI; MACROPHAGES, ALVEOLAR; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SWINE; VIRAL ENVELOPE PROTEINS;

EID: 84930422368     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.04.015     Document Type: Article

References (48)

1. Al-Gelban K.S. Intra-rator variability of primary care physicians in management of hyperlipidaemia. West Afr. J. Med. 2004, 23(1):69-73.
2. Allende R., Laegreid W.W., Kutish G.F., Galeota J.A., Wills R.W., Osorio F.A. Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J. Virol. 2000, 74(22):10834-10837.
3. Andreyev V.G., Wesley R.D., Mengeling W.L., Vorwald A.C., Lager K.M. Genetic variation and phylogenetic relationships of 22 porcine reproductive and respiratory syndrome virus (PRRSV) field strains based on sequence analysis of open reading frame 5. Arch. Virol. 1997, 142(5):993-1001.
4. Balasuriya U.B., MacLachlan N.J. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 2004, 102(3):107-129.
5. Chang C.C., Yoon K.J., Zimmerman J.J., Harmon K.M., Dixon P.M., Dvorak C.M., Murtaugh M.P. Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs. J. Virol. 2002, 76(10):4750-4763.
6. Collins J.E., Benfield D.A., Christianson W.T., Harris L., Hennings J.C., Shaw D.P., Goyal S.M., McCullough S., Morrison R.B., Joo H.S., et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J. Vet. Diagn. Invest. 1992, 4(2):117-126.
7. Costers S., Lefebvre D.J., Van Doorsselaere J., Vanhee M., Delputte P.L., Nauwynck H.J. GP4 of porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to immunoselection in vitro. Arch. Virol. 2010, 155(3):371-378.
8. Costers S., Vanhee M., Van Breedam W., Van Doorsselaere J., Geldhof M., Nauwynck H.J. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution. Virus Res. 2010, 154(1/2):104-113.
9. Delisle B., Gagnon C.A., Lambert M.E., D'Allaire S. Porcine reproductive and respiratory syndrome virus diversity of Eastern Canada swine herds in a large sequence dataset reveals two hypervariable regions under positive selection. Infect. Genet. Evol. 2012, 12(5):1111-1119.
10. Delputte P.L., Costers S., Nauwynck H.J. Analysis of porcine reproductive and respiratory syndrome virus attachment and internalization: distinctive roles for heparan sulphate and sialoadhesin. J. Gen. Virol. 2005, 86(Pt 5):1441-1445.
11. Domingo E., Mas A., Yuste E., Pariente N., Sierra S., Gutierrez-Riva M., Menendez-Arias L. Virus population dynamics, fitness variations and the control of viral disease: an update. Prog. Drug Res. 2001, 57:77-115.
12. Faaberg K.S., Even C., Palmer G.A., Plagemann P.G. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J. Virol. 1995, 69(1):613-617.
13. Goldberg T.L., Lowe J.F., Milburn S.M., Firkins L.D. Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection. Virology 2003, 317(2):197-207.
14. Gonin P., Pirzadeh B., Gagnon C.A., Dea S. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. J. Vet. Diagn. Invest. 1999, 11(1):20-26.
15. Gorbalenya A.E., Enjuanes L., Ziebuhr J., Snijder E.J. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006, 117(1):17-37.
16. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326(5953):734-736.
17. Jiang W., Jiang P., Li Y., Tang J., Wang X., Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet. Immunol. Immunopathol. 2006, 113(1/2):169-180.
18. Johnson C.R., Griggs T.F., Gnanandarajah J., Murtaugh M.P. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J. Gen. Virol. 2011, 92(Pt 5):1107-1116.
19. Leng C.L., Tian Z.J., Zhang W.C., Zhang H.L., Zhai H.Y., An T.Q., Peng J.M., Ye C., Sun L., Wang Q., Sun Y., Li L., Zhao H.Y., Chang D., Cai X.H., Zhang G.H., Tong G.Z. Characterization of two newly emerged isolates of porcine reproductive and respiratory syndrome virus from Northeast China in 2013. Vet. Microbiol. 2014, 171(1/2):41-52.
20. Li J., Murtaugh M.P. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes. Virology 2012, 433(2):367-376.
21. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin. Vaccine Immunol. 2007, 14(3):269-275.
22. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 2004, 102(3):155-163.
23. Mardassi H., Massie B., Dea S. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 1996, 221(1):98-112.
24. Mardassi H., Mounir S., Dea S. Molecular analysis of the ORFs 3 to 7 of porcine reproductive and respiratory syndrome virus, Quebec reference strain. Arch. Virol. 1995, 140(8):1405-1418.
25. Mateu E., Diaz I., Darwich L., Casal J., Martin M., Pujols J. Evolution of ORF5 of Spanish porcine reproductive and respiratory syndrome virus strains from 1991 to 2005. Virus Res. 2006, 115(2):198-206.
26. Meng X.J., Paul P.S., Halbur P.G. Molecular cloning and nucleotide sequencing of the 3'-terminal genomic RNA of the porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 1994, 75(Pt 7):1795-1801.
27. Meulenberg J.J. PRRSV, the virus. Vet. Res. 2000, 31(1):11-21.
28. Meulenberg J.J., van Nieuwstadt A.P., van Essen-Zandbergen A., Langeveld J.P. Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus. J. Virol. 1997, 71(8):6061-6067.
29. Nelsen C.J., Murtaugh M.P., Faaberg K.S. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J. Virol. 1999, 73(1):270-280.
30. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., Green A.L., Zimmerman J.J. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 2005, 227(3):385-392.
31. O'Donnell C.D., Vogel L., Wright A., Das S.R., Wrammert J., Li G.M., McCausland M., Zheng N.Y., Yewdell J.W., Ahmed R., Wilson P.C., Subbarao K. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. mBio 2012, 3(3).
32. Oleksiewicz M.B., Botner A., Toft P., Normann P., Storgaard T. Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. J. Virol. 2001, 75(7):3277-3290.
33. Oleksiewicz M.B., Stadejek T., Mackiewicz Z., Porowski M., Pejsak Z. Discriminating between serological responses to European-genotype live vaccine and European-genotype field strains of porcine reproductive and respiratory syndrome virus (PRRSV) by peptide ELISA. J. Virol. Methods 2005, 129(2):134-144.
34. Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., Zuckermann F., Laegreid W.W. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 2002, 302(1):9-20.
35. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 2002, 76(9):4241-4250.
36. Pejsak Z., Stadejek T., Markowska-Daniel I. Clinical signs and economic losses caused by porcine reproductive and respiratory syndrome virus in a large breeding farm. Vet. Microbiol. 1997, 55(1-4):317-322.
37. Pirzadeh B., Dea S. Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. J. Gen. Virol. 1997, 78(Pt 8):1867-1873.
38. Plagemann P.G. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Virology 2001, 290(1):11-20.
39. Plagemann P.G. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2004, 102(3):263-275.
40. Plagemann P.G., Rowland R.R., Faaberg K.S. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch. Virol. 2002, 147(12):2327-2347.
41. Rowland R.R., Steffen M., Ackerman T., Benfield D.A. The evolution of porcine reproductive and respiratory syndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. Virology 1999, 259(2):262-266.
42. Snijder E.J., Dobbe J.C., Spaan W.J. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J. Virol. 2003, 77(1):97-104.
43. Vanhee M., Costers S., Van Breedam W., Geldhof M.F., Van Doorsselaere J., Nauwynck H.J. A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains. Viral Immunol. 2010, 23(4):403-413.
44. Vu H.L., Kwon B., Yoon K.J., Laegreid W.W., Pattnaik A.K., Osorio F.A. Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J. Virol. 2011, 85(11):5555-5564.
45. Weiland E., Wieczorek-Krohmer M., Kohl D., Conzelmann K.K., Weiland F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet. Microbiol. 1999, 66(3):171-186.
46. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., Kragten C., van Buiten L., den Besten A., Wagenaar F., et al. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet. Q. 1991, 13(3):121-130.
47. Wissink E.H., van Wijk H.A., Kroese M.V., Weiland E., Meulenberg J.J., Rottier P.J., van Rijn P.A. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. J. Gen. Virol. 2003, 84(Pt 6):1535-1543.
48. Yang L., Frey M.L., Yoon K.J., Zimmerman J.J., Platt K.B. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch. Virol. 2000, 145(8):1599-1619.